Pharmacoeconomic assessment of two tocolysis protocols for the inhibition of premature delivery;Evaluación farmacoeconómica de dos protocolos de tocolisis para la inhibición del parto prematuro

Farmacia Hospitalaria

Volumn 29, Issue 1, 2005, Pages 18-25

  Ferriols Lisart, Rafael ^a   Nicolas Pico J ^a   Alos Alminana M ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Atosiban; Cost effectiveness; Pharmacoeconomy; Ritodrine

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; OXYTOCIN ANTAGONIST; RITODRINE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; LABOR; LUNG EDEMA; MEDICAL DECISION MAKING; PREMATURE LABOR; TOCOLYSIS;

EID: 16444370822     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(05)73631-x     Document Type: Article

References (30)

1. Husslein P, Quartorolo JP. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (Treasure) study protocol. Int J Clin Pract 2003; 57: 121-7.
2. Gyetvai K, Hannah ME, Donet ED, Ohisson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999; 94: 869-77.
3. García N, Aguilera C. Tratamiento tocolítico del parto prematuro. Med Clin (Barc) 2001; 117: 514-6.
4. McCombs J. Update on tocolytic therapy. Ann Pharmacother 1995; 29: 515-22.
5. Arrazola M, Díaz A, Domínguez I, Ramírez A, Ogáyar M. Efectos adversos y cuidados de enfermería en la administración de ritodrina. Enfermería Clínica 2002; 12: 188-92.
6. Husslein P. Development and clinical experience with the new evidence-based tocolytic atosiban. Acta Obstet Gynecol Scand 2002; 81: 633-41.
7. Sáez V, Germain A, Carvajal J. Atosiban, perspectivas sobre el manejo etiológico del parto prematuro. Rev Chil Obstet Ginecol 2002; 67: 249-55.
8. Moutquin J, Sherman D, Cohen H, Mohide P, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000; 182: 1191-9.
9. Azanza J, Cameán M, Cercós A, Domínguez-Gil A, Escriva J, Gobernado M, et al. Consenso sobre el diseño de un modelo farmacoeconómico útil para la valoración de antibióticos parenterales de uso hospitalario. Rev Esp Farmacoeconomía 1997; 1: 35-49.
10. Tejerizo-López L, Teijelo A, Sánchez-Sánchez M, García-Robles R, Moro J, Jiménez-Vicente F, et al. Edema pulmonar como complicación materna del uso de betamiméticos en gestación gemelar. Clin Invest Gin Obst 2001; 28: 22-33.
11. La Chapelle A, Benoit S, Bouregba M, Durand-Reville M, Raucoules-Aimé M. The treatment of severe pulmonary edema induced by beta adrenergic agonist tocolytic therapy with continuous positive airway pressure delivered by face mask. Anesth Analg 2002; 94: 1593-4.
12. Kerridge R, Glasziou P, Hillman K. The use of "quality-adjusted life years" (QALYs) to evaluate treatment in Intensive Care. Anesth Intens Care 1995; 23: 322-31.
13. Valentin L, Sladkevivius P, Kindahl H, Broeders A, Marsal K, Melin P. Effects of vasopressin antagonist in women with dismenorrea. Gynecol Obstet Invest 2000; 50: 170-7.
14. Goodwin T, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170: 474-8.
15. Goodwin T, Valenzuela G, Silver H, Hayashi R, Creasy G, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996; 13: 143-6.
16. European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomize, double-blind, controlled study. Acta Obstet Gynecol Scand 2001; 80: 413-22.
17. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Gynecol Reprod Biol 2001; 98: 177-85.
18. Romero R, Sibai B, Sánchez-Ramos L, Valenzuela G, Veille J, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173-83.
19. Valenzuela GJ, Sánchez-Ramos L, Romero R, Silver H, Koltun W, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000; 182: 1184-90.
20. Goodwin T, Valenzuela G, Silver H, Creasy G. Dose ranging study of the oxytocin anagonist in the treatment of preterm labour. Obstet Gynecol 1996; 88: 331-6.
21. Worlwide Atosiban versus beta-agonists study group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001; 108: 133-42.
22. Leveno K, Cunningham F. Beta-adrenergic agonists for preterm labour. N Engl J Med 1992; 327: 349-51.
23. Benedetti T, Caritis S. Treatment of preterm labor with beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 1758-60.
24. Besinger R, Iannuci T. Tocolytic therapy. En: Elder M, Lamont R, Romero R, eds. Preterm labor. New York: Churchill Livingstone, 1997. p. 243-97.
25. Hourdequin P, Bednarczyk L, Gabriel R, Harika G, Quereux C, Wahl P. Maternal complications from tocolytic treatment with beta-mimetics. Three cases of pulmonary edema. J Gynecol Obstet Biol Reprod 1996; 25: 528-32.
26. Pisano R, Rosenow E. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989; 110: 714-8.
27. Segarra A. La parte plana de la curva, donde el coste-efectividad encuentra la regla del rescate. En: Ortún V, eds. Gestión clínica y sanitaria. De la práctica diaria a la academia, ida y vuelta. Barcelona: Masson SA, 2003. p. 161-93.
28. Price PH. Review of betamimetic drugs for tocolysis. Report to special FDA public meeting on re-evaluation of ritodrine labelling. 28 October, 1992.
29. Coomarasamy A, Knox E, Gee H, Khan K. Oxytocin antagonists for tocolysis in preterm labour - a systematic review. Med Sci Monit 2002; 8 (11): RA268-73.
30. Shubert PJ. Atosiban. Clin Obstet Gynecol 1995; 38: 722-4.